A team of scientists from La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases
The scientific discovery, published in the prestigious journal Nature Communications could lead to the development of a new class of antibiotics and meet the challenge of rising antibiotic resistance.
Dr Mark Hulett and Dr Marc Kvansakul from the La Trobe Institute for Molecular Science said their team had demonstrated the peptide NaD1 found in the flowers of the ornamental tobacco plant Nicotiana alata has infection-busting qualities.
“Infectious diseases are a major global health problem, accounting for more than one in eight deaths and mortality rates are predicted to skyrocket over the next 30 years,” Dr Hulett said.
“Antibiotic resistance at the current rate will eventually lead to the exhaustion of effective long-term drug options. It’s imperative we develop new antibiotic treatments.”
Using the power of the Australian Synchrotron, the team led by Dr Hulett and Dr Kvansakul have shown in atomic detail how the tobacco plant peptide can target and destroy the micro-organism responsible for a dangerous fungal infection.
The peptide perforates the parachute-like outer layer of Candida albicans cells, ripping them apart and causing them to explode and die.
“They act in a different way to existing antibiotics and allow us to explore new ways of fighting infections.
“It’s an exciting discovery that could be harnessed to develop a new class of life-saving antimicrobial therapy to treat a range of infectious diseases, including multi-drug-resistant golden staph, and viral infections such as HIV, Zika virus, Dengue and Murray River Encephalitis.”
In 2014, Dr Hulett and Dr Kvansakul found NaD1 could also be effective in killing cancer cells.
Candida albicans is responsible for life-threatening infections in immune-compromised patients, including those diagnosed with cancer and transplant recipients. There are limited effective antibiotics available to treat the infection.
Nicotiana alata flowers naturally produce potent anti-fungal molecules for protection against disease. The plant is related, but different, to tobacco plants grown for commercial use.
Learn more: La Trobe’s infection-busting discovery
The Latest on: Antimicrobial therapy
via Google News
The Latest on: Antimicrobial therapy
- Needed: Antimicrobial Development on February 20, 2019 at 2:01 pm
The initiation of antimicrobial therapy is urgently needed in patients with serious acute bacterial infections. […]
- Hospital Antimicrobial Stewardship Programs Have Significant Value With Beneficial Clinical and Economic Impacts on February 20, 2019 at 7:40 am
Hospital antimicrobial stewardship programs (ASPs ... Savings were higher among hospitals with comprehensive ASPs which included therapy review and antibiotic restrictions. The researchers conclude th... […]
- Antibiotic Resistant Gene Blocked by Novel Combination Therapy on February 20, 2019 at 6:45 am
Scientists in Canada say they have found a method to block the VCC-1 enzyme, which disables the VCC-1 antimicrobial-resistance gene. VCC-1, a ß-lactamase gene, has been discovered in benign close rela... […]
- Silverlon® Antimicrobial Dressing Line Receives Contract Extension from Vizient, Inc. on February 19, 2019 at 6:46 am
Silverlon® antimicrobial silver-plated dressings provide 50-100xs ... in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds. Silverlon® Island W... […]
- Measuring vancomycin use by days of therapy underestimates exposure on February 18, 2019 at 5:48 am
Using days of therapy, or DOT, to estimate vancomycin use may underestimate ... told Infectious Disease News. “Because calculating antimicrobial exposure with intermittent dosing of vancomycin is chal... […]
- Chronic prostatitis caused by extended-spectrum β-lactamase-producing Escherichia coli managed using oral fosfomycin-A case report. on February 17, 2019 at 12:00 am
After 9 months of follow-up without antimicrobial treatment ... Accordingly, our report suggests that fosfomycin can be used as eradication therapy in a patient with a prior history of chronic prostat... […]
- Researchers Characterize Epidemiology of, Source of Infection in Febrile Neutropenia on February 16, 2019 at 7:10 am
and ceftazidime (7.5%), resulting in a 45.5% compliance rate with single antimicrobial therapy. The remaining patients received variable combination therapy. According to the researchers, the variabil... […]
- Handy graphene foam combos keep surfaces ice-free on February 13, 2019 at 8:53 am
The composites could be useful for wearable electronics, in heat therapy, in water treatment, in anti-icing and deicing work, in creating antimicrobial surfaces, and even in making resistive random-ac... […]
- Bringing Antimicrobial Susceptibility Testing (AST) to the Community on February 13, 2019 at 5:28 am
What is rapid antimicrobial susceptibility testing (AST ... science and biotechnology to address problems in medical diagnostics, food safety, and therapy. Dr. Segal received her Ph.D. in Chemical Eng... […]
via Bing News